Met Life Investment Management, LLC Avidity Biosciences, Inc. Transaction History
Met Life Investment Management, LLC
- $18.1 Billion
- Q1 2025
A detailed history of Met Life Investment Management, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 65,873 shares of RNA stock, worth $2.01 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
65,873
Previous 66,795
1.38%
Holding current value
$2.01 Million
Previous $1.94 Million
0.1%
% of portfolio
0.01%
Previous 0.01%
Shares
35 transactions
Others Institutions Holding RNA
# of Institutions
244Shares Held
116MCall Options Held
289KPut Options Held
998K-
Janus Henderson Group PLC London, X011.4MShares$349 Million0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$347 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$296 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$283 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.75MShares$267 Million4.23% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.59B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...